ALLOGENEIC DONOR-DERIVED CD19-CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS FOR RELAPSED B-CELL MALIGNANCIES AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION

被引：0
|
作者：
Muhsen, I. N. [1 ]
Cruz, H. [2 ,3 ]
Zhang, H. [2 ,3 ]
Thakkar, S. G. [2 ,3 ]
Grilley, B. [2 ,3 ]
Gee, A. P. [2 ,3 ]
Heslop, H. [2 ,3 ]
Brenner, M. [2 ,3 ]
Ramos, C. A. [2 ,3 ]
机构：
[1] Houston Methodist, Med, Houston, TX USA
[2] Baylor Coll Med, Ctr Cell & Gene Therapy, Texas Childrens Hosp, Houston, TX USA
[3] Houston Methodist Hosp, Houston, TX 77030 USA
来源：
CYTOTHERAPY | 2022年 / 24卷 / 05期
关键词：
Allogeneic; CAR T cells;
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
18
引用
下载
收藏
页码：S27 / S28
页数：2
相关论文
共 50 条
  • [21] Use of chimeric antigen receptor T cells in allogeneic hematopoietic stem cell transplantation
    Liu, Jun
    Zhang, Xi
    Zhong, Jiang F.
    Zhang, Cheng
    IMMUNOTHERAPY, 2019, 11 (01) : 35 - 44
  • [22] Allogeneic anti-CD19 CAR T cells: new perspectives in the treatment of B-cell malignancies that progress after allogeneic stem cell transplantation?
    Heiblig, Mael
    Salles, Gilles
    Thomas, Xavier
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S5 - S8
  • [23] Donor-derived CD19 chimeric antigen receptor T cells
    Singh, Nathan
    Barrett, David M.
    CURRENT OPINION IN HEMATOLOGY, 2015, 22 (06) : 503 - 508
  • [24] Donor origin CAR19 T cell infusion for B-ALL relapsed after allogeneic hematopoietic stem cell transplantation
    Yang, Xiaofei
    Dai, Haiping
    Kang, Liqing
    Qu, Changju
    Li, Zheng
    Yin, Jia
    Qiu, Huiying
    Fu, Chengcheng
    Han, Yue
    Jin, Zhengming
    Ma, Xiao
    Zhu, Xiamin
    Yu, Lei
    Wu, Depei
    Tang, Xiaowen
    HEMATOLOGICAL ONCOLOGY, 2019, 37 (05) : 655 - 658
  • [25] Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation
    Kochenderfer, James N.
    Dudley, Mark E.
    Carpenter, Robert O.
    Kassim, Sadik H.
    Rose, Jeremy J.
    Telford, William G.
    Hakim, Frances T.
    Halverson, David C.
    Fowler, Daniel H.
    Hardy, Nancy M.
    Mato, Anthony R.
    Hickstein, Dennis D.
    Gea-Banacloche, Juan C.
    Pavletic, Steven Z.
    Sportes, Claude
    Maric, Irina
    Feldman, Steven A.
    Hansen, Brenna G.
    Wilder, Jennifer S.
    Blacklock-Schuver, Bazetta
    Jena, Bipulendu
    Bishop, Michael R.
    Gress, Ronald E.
    Rosenberg, Steven A.
    BLOOD, 2013, 122 (25) : 4129 - 4139
  • [26] DONOR-DERIVED, CD19-DIRECTED, CAR-MODIFIED T CELLS INFUSED AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION AS PRE-EMPTIVE DONOR LYMPHOCYTE INFUSION IN PATIENTS WITH CD19+MALIGNANCIES
    Kebriaei, P.
    Huls, H.
    Ciurea, S.
    Liu, T.
    Singh, H.
    Su, S.
    Hosing, C.
    Olivares, S.
    Figliola, M.
    Kumar, P.
    Jena, B.
    Maiti, S.
    McNiece, I.
    Lee, D.
    Tewari, P.
    Popat, U.
    Alousi, A.
    Oran, B.
    Shah, N.
    Rezvani, K.
    Forget, M.
    Ang, S.
    Jackson, R.
    Rondon, G.
    Kantarjian, H.
    Hackett, P.
    Shpall, E.
    Champlin, R.
    Cooper, L.
    HAEMATOLOGICA, 2015, 100 : 320 - 320
  • [27] Feasibility and Safety of CD19 Chimeric Antigen Receptor T Cell Treatment for B Cell Lymphoma Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
    Schubert, Maria-Luisa
    Dietrich, Sascha
    Stilgenbauer, Stephan
    Schmitt, Anita
    Pavel, Petra
    Kunz, Alexander
    Bondong, Andrea
    Wegner, Mandy
    Stadtherr, Peter
    Jung, Susanne
    Ho, Anthony D.
    Mueller-Tidow, Carsten
    Schmitt, Michael
    Dreger, Peter
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (09) : 1575 - 1580
  • [28] Genome editing of donor-derived T cells to generate allogeneic chimeric antigen receptor-modified T cells: optimizing αβ T-cell-depleted haploidentical hematopoietic stem cell transplantation
    Wiebking, Volker
    Lee, Ciaran M.
    Mostrel, Nathalie
    Lahiri, Premanjali
    Bak, Rasmus
    Bao, Gang
    Roncarolo, Maria Grazia
    Bertaina, Alice
    Porteus, Matthew H.
    HAEMATOLOGICA, 2021, 106 (03) : 847 - 858
  • [29] Impact of Previous Allogeneic Hematopoietic Stem Cell Transplantation on Chimeric Antigen Receptor (CAR) T Cell Treatment for Relapsed/Refractory Multiple Myeloma
    Kirchberg, Janine
    Fischer, Luise
    Born, Patrick
    Brunner, Franziska
    Morgner, Charlotte
    Fuerst, Daniel
    Heyn, Simone
    Bach, Enrica
    Brueckner, Mandy
    Jentzsch, Madlen
    Wang, Song-Yau
    Boettcher, Sebastian
    Franke, Georg-Nikolaus
    Schrezenmeier, Hubert
    Platzbecker, Uwe
    Merz, Maximilian
    Vucinic, Vladan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (09): : e277 - e282
  • [30] Allogeneic Donor-Derived Myeloid Antigen Directed CAR-T Cells - for Relapsed/Refractory Acute Myeloid Leukemia in Children after Allogeneic Hematopoietic Stem Cell Transplantation: Report of Three Cases
    Shelikhova, Larisa
    Rakhteenko, Arina
    Molostova, Olga
    Kurnikova, Elena
    Ukrainskaya, V
    Muzalevsky, Yakov
    Pershin, Dmitry
    Popov, Alexander
    Kulakovskaya, Elena
    Baidildina, Dina
    Stepanov, Alexey
    Osipova, Elena
    Novichkova, Galina
    Maschan, Alexey
    Maschan, Michael
    BLOOD, 2022, 140 : 4600 - 4601
12345